Choropleth Mapping of Cervical Cancer Screening in South Africa Using Healthcare Facility-level Data from the National Laboratory Network
- PMID: 29546199
- PMCID: PMC5690409
- DOI: 10.3934/publichealth.2016.4.849
Choropleth Mapping of Cervical Cancer Screening in South Africa Using Healthcare Facility-level Data from the National Laboratory Network
Abstract
Background: In South Africa, cervical cancer remains among the most common cancers and a leading cause of cancer death. Co-infection with HIV increases the risk of developing cervical pre-cancer and cancer. We analysed National Health Laboratory Service cervical cytology data to investigate geographic variations of Pap smear coverage, quality, and high grade lesions.
Methods: Facility-level data were extracted from the NHLS for April 2013-March 2014. We present results and choropleth maps detailing coverage, adequacy and high-grade Pap smear cytology abnormalities defined as Pap smears suspicious for invasive carcinoma, high-grade squamous intraepithelial lesions (HSIL) or atypical squamous cells: cannot exclude HSIL (ASC-H).
Results: 4,562 facilities submitted 791,067 cytology slides. The interquartile range (IQR) for Pap smear coverage among HIV-infected women was 26-41%; similar to coverage in women aged 30 and older (IQR: 26-42%). 6/52 districts had adequacy rates above the national standard (70%) and 2/52 districts had adequacy rates below 35%. We observed marked variation in Pap smear abnormalities across the country, with the proportion of high-grade cytology abnormalities ≥0.3% in 17/52 districts.
Conclusion: Using district-level choropleth maps, we are able to display variations in Pap smear coverage, quality, and results across South Africa. This approach may be used to improve resource allocation, achieving better equity in cervical cancer prevention.
Keywords: High grade squamous intraepithelial lesion (HSIL); Pap smear; South Africa; cervical cancer screening; choropleth map.
Conflict of interest statement
Conflict of Interest: The authors declare no conflict of interest.
Figures
References
-
- Snyman LC. Prevention of cervical cancer—how long before we get it right? S Afr J Obstet Gynaecol. 2012;19:223.
-
- Denny LE. Prevention of cervical cancer. Reprod Health Matters. 2008;16:18–31. - PubMed
-
- Torre LA, Bray F, Siegel RL, et al. Global Cancer Statistics, 2012. A Cancer J Clin. 2015;65:87–108. - PubMed
-
- Firnhaber CS, Michelow P. Cervical cancer and the human immunodeficiency virus: A review. South Afr J HIV Med. 2009;10:23–27.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous